Clinical sequencing technology identifies new targets in diverse cancers
Friday, June 7, 2013 - 15:30
in Health & Medicine
Novel abnormalities in the FGFR gene were identified in a spectrum of cancers, and preliminary results with cancer cells harboring FGFR fusions suggested that some patients with these cancers may benefit from treatment with FGFR inhibitor drugs.